Exane Derivatives’s Lumentum LITE Stock Holding History
Bought
Maintained
Sold
Other funds holding LITE
Exane Derivatives's LITE Position: Q2 2022 in Review
Exane Derivatives reduced its Lumentum (LITE) stake by 100% in Q2 2022, selling an estimated $105K and leaving 6 shares worth $476. The position accounts for ﹤0.01% of the portfolio, ranked #575.
Exane Derivatives first reported a position in LITE in Q2 2021 and has held it in 5 quarters since. The position peaked at $170K in Q4 2021. 467 funds tracked by Wall St. Rank hold LITE as of Q2 2022.
- Exane Derivatives held 6 shares of Lumentum worth $476 as of Q2 2022.
- Exane Derivatives sold 1,231 Lumentum shares in Q2 2022, an estimated $105K.
- Lumentum made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #575 holding.
- Exane Derivatives first reported a position in Lumentum in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's Lumentum position peaked at $170K in Q4 2021.
- 467 funds tracked by Wall St. Rank held Lumentum as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.